Sixfold Bioscience
Delivering RNA therapies.
London, United Kingdom · Founded 2018 · $10.5M raised
- Headquarters
- London
- Employees
- 11–50
- Founded
- 2018
- Website
- sixfold.bio
- Total Funding
- $10.5M
- Last Round
- $10.5M SeedDec 2021
- Rounds
- 1
About
Sixfold is focused on the commercialisation of its patented drug delivery systems for RNA therapeutics such as siRNAs for gene silencing and mRNAs for gene expression.
Summary
Sixfold Bioscience is a Biotech company based in London, United Kingdom, founded in 2018. It has raised $10.5M in total across 1 round, most recently a $10.5M Seed round in Dec 2021. Investors include Cantos, Lombard Street Ventures and Pi Campus.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2021
Investors
Similar Companies
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/sixfoldbioscience"><img src="https://indexed.vc/api/badge/company/sixfoldbioscience" alt="Sixfold Bioscience on Indexed.vc" width="260" height="76" /></a>